Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML)

Clinical trial NCT01662505 · COMPLETED

Trial details

NCT number: NCT01662505
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2012-08-01
Primary completion: 2015-05-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.